SZ
StageZero Life Sciences Ltd.
SZLSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $630.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.17x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Rev. growth 201.33%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 10.64%
Net margin 300.79%
FCF margin 92.98%
Quality
79 /100
Excellent ROIC 151.85%
ROA 1,629.25%
Asset turnover 5.42x
Debt
50 /100
Moderate Current ratio 0.04x
Int. coverage -37.63x
Net debt/EBITDA -0.17x
Stability
35 /100
Moderate Beta 0.34x
Rev. volatility 1,671.49%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SZLSF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James R. Howard-Tripp
Employees
40
Headquarters
Richmond Hill
Evenimente viitoare
18 NOV.
Earnings
Upcoming earnings report